-
Vacuolin-1 Workflow for Lysosomal Exocytosis
2026-08-17
Vacuolin-1 provides a selective way to separate calcium-triggered lysosome-plasma membrane fusion from broader trafficking or secretion changes. This guide translates recent MPS IVA cartilage findings into practical β-hexosaminidase, LAMP1, membrane-repair, and signaling workflows.
-
T. pallidum, Mitochondrial ROS, and Hepatocyte Apoptosis
2026-08-17
The reference study identifies mitochondrial reactive oxygen species accumulation and cardiolipin peroxidation as central events in Treponema pallidum-induced intrinsic apoptosis in hepatocytes. Its integrated analysis of mitochondrial function, pore opening, oxidative injury, and apoptotic signaling provides a framework for mitochondrial permeability transition pore detection and related cell death mechanism research.
-
TSPAN18-STIM1 Signaling in Prostate Cancer Bone Metastasis
2026-08-16
Zhou et al. identify TSPAN18 as a regulator of STIM1 stability, showing that it prevents TRIM32-mediated ubiquitination and sustains store-operated calcium entry in prostate cancer cells. The study connects this molecular mechanism to migration, invasion, bone metastasis, and adverse clinical features, providing a framework for investigating the STIM1-Ca2+ signaling axis as a therapeutic vulnerability.
-
p-Cresyl Sulfate and Aortic Valve Calcification
2026-08-15
The reference study identifies p-cresyl sulfate as a mechanistic driver of calcification in porcine aortic valvular interstitial cells, linking HIF-1α activation and klotho/SIRT1 disruption to NF-κB and RUNX2 signaling. Its cell and rat CKD experiments suggest that klotho and SIRT1 activation may be useful experimental strategies for investigating uremia-associated calcific aortic valve disease, while stopping short of establishing a clinical treatment.
-
Amiloride (MK-870) Workflows for Ion Transport
2026-08-14
Amiloride (MK-870) helps researchers separate epithelial sodium flux from uPAR-associated uptake and signaling. This practical guide connects dose-controlled inhibition, endocytosis assays, and nanovaccine mechanism studies while emphasizing controls that prevent off-target interpretation.
-
Sumatriptan B4981 for Reliable Cell Assays
2026-08-14
This scenario-driven guide explains how Sumatriptan, SKU B4981, can be integrated into cell viability, proliferation, cytotoxicity, and inflammation workflows without confusing receptor-mediated effects with nonspecific toxicity. It combines product parameters, concentration guidance, assay controls, and translational evidence to support more reproducible experimental decisions.
-
Ionomycin Calcium Salt: Calcium Signaling Guide
2026-08-13
Ionomycin calcium salt is a calcium ionophore that raises intracellular Ca2+ by mobilizing cellular stores and promoting extracellular influx. Product-dossier evidence supports its use in calcium signaling studies, secretion assays, muscle protein regulation, and model-specific cancer research, while the prostate cancer literature provides a distinct framework for interpreting Ca2+-dependent signaling.
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-08-13
Borchert et al. linked homologous recombination repair defects, or BRCAness, with olaparib sensitivity in malignant pleural mesothelioma models. Their integrated cell-line and patient-sample analysis highlights BAP1-associated vulnerability, combination effects with cisplatin, and gene-expression markers that may support biomarker-guided PARP inhibition.
-
D-Lin-MC3-DMA in Reliable RNA Assays
2026-08-12
Learn how D-Lin-MC3-DMA (SKU A8791) can support controlled siRNA and mRNA lipid nanoparticle workflows when viability, transfection, and cytotoxicity readouts are difficult to reconcile. This practical guide connects ionizable-lipid chemistry, formulation handling, assay controls, and evidence from a 216-formulation mRNA study.
-
Refining In Vitro Drug Response Assessment in Cancer
2026-08-12
Hannah R. Schwartz’s 2022 dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an in vitro cancer drug response. The framework supports more precise interpretation of cytostatic versus cytotoxic effects and offers practical guidance for designing assays that capture both response magnitude and timing.
-
Self-Amplifying RNA Vaccines for Influenza
2026-08-11
This study shows that influenza RNA vaccine performance depends strongly on both viral subtype and RNA modality. In a murine model, low-dose self-amplifying RNA achieved durable antibody responses and complete protection against influenza B challenge, addressing a limitation observed with conventional mRNA vaccines.
-
Saquinavir Beyond the Target: From Protease to Permeability
2026-08-11
Saquinavir is more than a reference HIV protease inhibitor: it is a translational probe for connecting viral target engagement, intracellular exposure, membrane partitioning, and assay reproducibility. This article outlines a practical strategy for advancing Saquinavir from antiretroviral drug research into evidence-driven permeability and exploratory cancer research workflows.
-
DOTAP Workflows for Nucleic Acid Delivery
2026-08-10
Build more reproducible DNA, RNA, and antisense oligonucleotide delivery workflows with DOTAP, from first-pass complexation screens to functional genomics validation. A recent immune-metabolic nanomedicine study adds a useful design principle: evaluate not only cargo activity, but also where the formulation delivers it and which cellular compartments respond.
-
Biomimetic mRNA Nanovaccines Target Tumor Neutrophils
2026-08-09
A 2026 study developed CD300LD-targeted, tumor-cell-membrane-coated liposomes carrying albumin-fused IL-36γ mRNA to reprogram tumor-associated neutrophils in hepatocellular carcinoma. The platform produced strong antitumor immune responses and increased mouse survival to 85%, while also illustrating how carefully characterized primary neutrophils can support mechanistic nanomedicine research.
-
Clathrin-Mediated Entry of Type III Grass Carp Reovirus
2026-08-08
Wang et al. used pharmacological inhibition, transmission electron microscopy, and quantitative PCR to define how genotype III grass carp reovirus enters CIK cells. Their results implicate a dynamin-dependent, clathrin-mediated and endosomal pH-sensitive route, while also showing that several commonly used endocytosis inhibitors do not block infection under the tested conditions.